BioLife Solutions, Inc. $BLFS Stock Sold by Stephens Investment Management Group LLC

Stephens Investment Management Group LLC cut its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 3.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 685,834 shares of the medical equipment provider’s stock after selling 22,832 shares during the period. Stephens Investment Management Group LLC’s holdings in BioLife Solutions were worth $26,645,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Public Sector Pension Investment Board raised its stake in BioLife Solutions by 7.7% during the 3rd quarter. Public Sector Pension Investment Board now owns 146,411 shares of the medical equipment provider’s stock valued at $5,653,000 after acquiring an additional 10,419 shares in the last quarter. HighTower Advisors LLC acquired a new position in shares of BioLife Solutions during the third quarter valued at $237,000. Alberta Investment Management Corp acquired a new position in shares of BioLife Solutions during the third quarter valued at $13,928,000. First Trust Capital Management L.P. bought a new stake in shares of BioLife Solutions during the third quarter valued at about $55,365,000. Finally, Maryland State Retirement & Pension System bought a new stake in shares of BioLife Solutions during the third quarter valued at about $370,000. 93.24% of the stock is owned by institutional investors.

Analysts Set New Price Targets

BLFS has been the subject of several research analyst reports. William Blair set a $31.00 price objective on shares of BioLife Solutions in a report on Thursday, July 23rd. Weiss Ratings raised shares of BioLife Solutions from a “sell (d-)” rating to a “hold (c)” rating in a research note on Tuesday, September 22nd. Zacks Research downgraded shares of BioLife Solutions from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 21st. Benchmark lowered shares of BioLife Solutions from a “buy” rating to a “hold” rating in a research note on Monday, August 10th. Finally, Jefferies Financial Group cut shares of BioLife Solutions from a “buy” rating to a “hold” rating and increased their price objective for the company from $30.00 to $31.00 in a report on Thursday, July 23rd. One research analyst has rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $31.38.

Read Our Latest Research Report on BLFS

BioLife Solutions Stock Performance

BLFS opened at $38.61 on Friday. BioLife Solutions, Inc. has a one year low of $17.86 and a one year high of $39.76. The stock’s fifty day moving average is $38.21 and its 200-day moving average is $28.96. The company has a market capitalization of $1.89 billion, a PE ratio of 33.28 and a beta of 1.82.

BioLife Solutions Profile

(Free Report)

BioLife Solutions, Inc. develops and supplies products and services used in the development and commercial production of cell and gene therapies and other biologic medicines. Its offerings support the handling, preservation, storage and distribution of sensitive biological materials. The company’s products include CryoStor and HypoThermosol preservation media, as well as CellSeal bags designed for cryogenic storage. BioLife also provides temperature-controlled storage and repository services for biological materials through its SciSafe business.

Read More

Want to see what other hedge funds are holding BLFS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report).

Institutional Ownership by Quarter for BioLife Solutions (NASDAQ:BLFS)

Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.